Patents by Inventor Thomas A. MCMURROUGH

Thomas A. MCMURROUGH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENE EDITING WITH A MODIFIED ENDONUCLEASE
    Publication number: 20240150796
    Abstract: An engineered nuclease with unique binding and cleavage properties and methods to alter cellular gene expression using said modified endonucleases for gene editing.
    Type: Application
    Filed: May 2, 2023
    Publication date: May 9, 2024
    Inventors: Brent E. STEAD, Thomas A. MCMURROUGH, Odisho K. ISRAEL
  • Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing
    Patent number: 11814658
    Abstract: Methods to edit genes by administering a chimeric nuclease to a cell or organism without the use of a viral vector.
    Type: Grant
    Filed: November 15, 2022
    Date of Patent: November 14, 2023
    Assignee: Specific Biologics Inc.
    Inventors: David R. Edgell, Thomas A. McMurrough, Brent E. Stead, Odisho K. Israel
  • LIPID-ENCAPSULATED DUAL-CLEAVING ENDONUCLEASE FOR DNA AND GENE EDITING
    Publication number: 20220195404
    Abstract: Methods to edit genes by administering a chimeric nuclease to a cell or organism without the use of a viral vector.
    Type: Application
    Filed: October 29, 2021
    Publication date: June 23, 2022
    Inventors: David R. EDGELL, Thomas A. MCMURROUGH, Brent E. STEAD, Odisho K. ISRAEL